Blog

  • David Nuttall – 2015 Parliamentary Question to the Department of Health

    David Nuttall – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Nuttall on 2015-12-02.

    To ask the Secretary of State for Health, how many items of correspondence his Department has received from (a) the Chair and (b) other members of the All Party Parliamentary Group on Smoking and Health in each of the last five years.

    Jane Ellison

    The Department would incur a disproportionate cost in calculating how many items of correspondence have been received from the All Party Parliamentary Group on Smoking and Health (APPG) in each of the last five years.

    592 letters from the APPG have been recorded as received by the Department’s Ministers over that period. The Group may also have written to officials direct but this information is not collected centrally.

  • Barbara Keeley – 2015 Parliamentary Question to the Department of Health

    Barbara Keeley – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Barbara Keeley on 2015-12-02.

    To ask the Secretary of State for Health, pursuant to the Oral Answer of 17 November 2015, Official Report, column 515, on non-hospital care, on what date he commissioned Paul Johnson of the Institute for Fiscal Studies to examine pressures in the care home sector; and if he will make a statement.

    Alistair Burt

    Paul Johnson has not been commissioned to examine pressures in the care home sector, nor are there any plans to commission him or the Institute for Fiscal Studies to undertake such a review.

  • Ian Blackford – 2015 Parliamentary Question to the Department of Health

    Ian Blackford – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ian Blackford on 2015-12-02.

    To ask the Secretary of State for Health, what evidence his Department holds on the prevalence of off-label prescribing among (a) specialist clinicians, (b) GPs, (c) nurses and (d) other medical professionals.

    George Freeman

    The Department does not hold the information requested. The Health and Social care Information Centre has published information on prescribing data by British National Formulary chapter.

    Where clinically appropriate, off-label prescribing is supported in guidance given to prescribers by both the General Medical Council and by the Medicines and Healthcare products Regulatory Agency. Prescribing in this way is part and parcel of normal every day clinical practice. It is very common in paediatric and palliative care.

    Discussions relating to the Access to Medical Treatments (Innovation) Bill are considering how a potential database covering off-label use could be constituted.

  • Ian Blackford – 2015 Parliamentary Question to the Department of Health

    Ian Blackford – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ian Blackford on 2015-12-02.

    To ask the Secretary of State for Health, what discussions his Department has had with the General Medical Council on amending guidance related to the prescription of off-label drugs and subsequent personal liability.

    George Freeman

    The Government has made no such assessment and has not had discussions with the General Medical Council (GMC) on amending their guidance related to the prescription of off-label drugs and subsequent personal liability. The GMC is responsible for the assessment of its national guidance and this is kept under review as part of GMC’s normal internal governance arrangements.

    As part of its response to the Off-Patent Drugs Bill, the Government has discussed a range of issues around off-label prescribing with a wide range of stakeholders, including the GMC. Working with the Department of Health, the GMC has recently published a Hot Topic on ‘Prescribing unlicensed medicines.’ This on-line tool explains GMC’s prescribing guidance and assures doctors of the clinical appropriateness of unlicensed and off-label prescribing. A copy of this is available at:

    http://www.gmc-uk.org/guidance/28349.asp

    “

  • Ian Blackford – 2015 Parliamentary Question to the Department of Health

    Ian Blackford – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ian Blackford on 2015-12-02.

    To ask the Secretary of State for Health, what assessment he has made of the effect of guidance from the General Medical Council on the personal liability taken on by medical professionals when prescribing off-label on the rate of off-label prescribing.

    George Freeman

    The Government has made no such assessment and has not had discussions with the General Medical Council (GMC) on amending their guidance related to the prescription of off-label drugs and subsequent personal liability. The GMC is responsible for the assessment of its national guidance and this is kept under review as part of GMC’s normal internal governance arrangements.

    As part of its response to the Off-Patent Drugs Bill, the Government has discussed a range of issues around off-label prescribing with a wide range of stakeholders, including the GMC. Working with the Department of Health, the GMC has recently published a Hot Topic on ‘Prescribing unlicensed medicines.’ This on-line tool explains GMC’s prescribing guidance and assures doctors of the clinical appropriateness of unlicensed and off-label prescribing. A copy of this is available at:

    http://www.gmc-uk.org/guidance/28349.asp

    “

  • Andrew Rosindell – 2015 Parliamentary Question to the Department of Health

    Andrew Rosindell – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Rosindell on 2015-12-02.

    To ask the Secretary of State for Health, pursuant to the Answer of 23 November 2015 to Question 16779, if he will assess the extent to which grants made by his Department to Action on Smoking and Health were used for activities designed to influence his Department, other departments or Parliament.

    Jane Ellison

    The conditions applicable to grants awarded to Action on Smoking and Health (ASH) are set out in the grant award letters. The Department has made clear that none of this funding is to be used for lobbying purposes.

    ASH’s compliance with the conditions of the grant is assessed at the grant monitoring meetings held between the Deputy Director of tobacco control and representatives from ASH as well as in the final full year grant monitoring and governance reports.

  • Jonathan Ashworth – 2015 Parliamentary Question to the Department of Health

    Jonathan Ashworth – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jonathan Ashworth on 2015-12-02.

    To ask the Secretary of State for Health, on how many occasions a special adviser in his Department accompanied a Minister on an overseas trip since May 2015.

    Jane Ellison

    A special adviser has accompanied a Minister on one overseas trip since May 2015.

  • Mark Tami – 2015 Parliamentary Question to the Department of Health

    Mark Tami – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Tami on 2015-12-02.

    To ask the Secretary of State for Health, what plans his Department has to work with the Department for Education on increasing awareness in schools of stem cell donation.

    Jane Ellison

    The Department funds charities such as Anthony Nolan who have campaigns to promote awareness in schools.

  • Mark Tami – 2015 Parliamentary Question to the Department of Health

    Mark Tami – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Tami on 2015-12-02.

    To ask the Secretary of State for Health, what assessment he has made of recent progress in increasing the (a) number of people on and (b) quality of the stem cell and bone marrow registers; and if he will make a statement.

    Jane Ellison

    The total number of registered donors on the Anthony Nolan and NHS Stem Cell Registry continues to expand. In 2010 the total number of registered United Kingdom donors was 770,000 but by the end of 2014 was in excess of one million. Investment by the Department has supported our delivery partners NHS Blood and Transplant and the charity Anthony Nolan to recruit a cohort of young male donors that are approximately six times more likely to be able to donate. Over 19,000 additional donors are planned to be recruited in the current financial year.

    Quality is a key issue for the clinical usefulness of cord blood samples. The collection of cord blood is arranged to maximise the proportion of samples with the highest quality. The number of banked cord samples of clinical grade continues to increase with in excess of 15,000 now banked.

  • Mark Tami – 2015 Parliamentary Question to the Department of Health

    Mark Tami – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Tami on 2015-12-02.

    To ask the Secretary of State for Health, what steps the Government is taking to increase the level of stem cell donations by people of mixed ethnicity.

    Jane Ellison

    The Department is supporting the provision of stem cells for patients through our key delivery partners, Anthony Nolan and NHS Blood and Transplant. They continue to specifically recruit adult bone marrow donors from the Black, Asian and Minority Ethnic (BAME) communities and we have agreed with them a target to recruit at least 3,000 new adult male bone marrow donors from the BAME community this year.

    It is difficult to find a perfectly matched donor for patients of mixed ethnicity, and for this reason the Department has continued to support the collection of cord blood stem cells. Cord blood stem cells are more tolerant of minor mis-matches and therefore particularly important to patients unable to find a suitable adult bone marrow donor.

    The Department continues to support the National BAME Transplant Alliance with the aim of raising awareness about the need for stem cell and organ donation, increasing the number of people from a BAME background on the bone marrow and organ donation registers and increasing the number of people from BAME communities who can benefit from either a stem cell or organ transplant.